Rady Children's Institute Genomic Biorepository

This study, called the Rady Children's Institute Genomic Biorepository, is collecting biological samples like blood, along with genetic information (genomic sequences from DNA and RNA) and health details. The goal is to create a large, standardized resource for future research into genetic diseases, especially those affecting children. Researchers hope this collection will help them better understand the causes and treatments of childhood diseases, improve genetic diagnoses, and develop better ways to manage these conditions. A small portion of the collected samples will undergo genetic analysis right away. This study is open to people of all ages, races, genders, and health statuses, including pregnant women, newborns, and children. The study is currently unclear on its recruitment status.

Study design
This is an interventional study planning to enroll 102,000 participants. It is designed to collect and store biological samples and genetic information for future research.
What's involved
You would provide biological samples, such as blood, for storage in the Biorepository. A subset of these samples will undergo genetic analysis.
Compensation
Not stated in the trial record.
Follow-up
The study plans to collect samples yearly through study completion, estimated to be 40 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02917460

Rady Children's Institute Genomic Biorepository

Recruiting
NAAll AgesInterventionalHealth services
Rady Pediatric Genomics & Systems Medicine Institute
~102,000 participants
Updated 2022-12-12 on ClinicalTrials.gov
What's tested:Genomic sequencing and molecular diagnostic results, if any

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of samples enrolled per year
Measured over Yearly through study completion estimated to be 40 years
Genetic Diseases
1 sites across 1 states
California1
  • Stephen Kingsmore, MD, MSc · PRINCIPAL_INVESTIGATOR · Rady Pediatric Genomics & Systems Medicine Institute

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All ages, races, genders, ethnicities, and health status will be eligible for participation. Enrollment will include that following vulnerable populations: pregnant women, neonates, fetuses, those with cognitive disabilities, pediatric patients, minorities, and employees.

Exclusion

None
  • Number of samples enrolled per yearYearly through study completion estimated to be 40 years

    Establishment of a Biorepository for genomic/precision medicine use in pediatric population. This will make samples available to study rare genetic disorders, screening methods, diagnostic methods, other "omics", and bench research for possible treatments.